[EN] SUBSTITUTED HETEROARYL- AND ARYL- CYCLOPROPYLAMINE ACETAMIDES AND THEIR USE<br/>[FR] ACÉTAMIDES D'HÉTÉROARYL- ET ARYL-CYCLOPROPYLAMINE SUBSTITUÉS ET LEUR UTILISATION
申请人:ORYZON GENOMICS SA
公开号:WO2011042217A1
公开(公告)日:2011-04-14
The invention relates to compounds of Formula (I): (A')x-(A)-(B)-(Z)-(L)-C(=O)NH2 or pharmaceutically acceptable salts or solvates thereof, wherein: (A) is heteroaryl or aryl; each (A'), if present, is indepedently chosen from aryl, arylalkoxy, arylalkyl, heterocyclyl, aryloxy, halo, alkoxy, haloalkyl, cycloalkyl, haloalkoxy, and cyano, wherein each (A') is substituted with 0, 1, 2 or 3 substituents independently chosen from halo, haloalkyl, aryl, arylalkoxy, alkyl, alkoxy, cyano, sulfonyl, sulfinyl, and carboxamide; X is 0, 1, 2, or 3; (B) is a cyclopropyl ring, wherein (A) and (Z) are covalently bonded to different carbon atoms of (B); (Z) is -NH-; and (L) is -(CH2)mCR1,R2-, wherein m is 0, 1, 2, 3, 4, 5, or 6, and wherein R1and R2 are each independently hydrogen or C1-C6 alkyl; provided that, if (L) is -CH2- or -CH(CH3)-, then X is not 0. The compounds of the invention are useful in the treatment of diseases such as cancer and neurodegenerative diseases.
该发明涉及以下式(I)的化合物:(A')x-(A)-(B)-(Z)-(L)-C(=O)NH2或其药学上可接受的盐或溶剂,其中:(A)是杂环芳基或芳基;每个(A')(如果存在)独立选择自芳基、芳基烷氧基、芳基烷基、杂环烷基、芳氧基、卤素、烷氧基、卤代烷基、环烷基、卤代烷氧基和氰基,其中每个(A')被0、1、2或3个取代基取代,独立选择自卤素、卤代烷基、芳基、芳基烷氧基、烷基、烷氧基、氰基、磺酰基、亚砜基和羧酰胺;X为0、1、2或3;(B)为环丙基环,其中(A)和(Z)与(B)的不同碳原子共价连接;(Z)为-NH-;(L)为-(CH2)mCR1,R2-,其中m为0、1、2、3、4、5或6,且R1和R2各自独立地为氢或C1-C6烷基;但条件是,如果(L)为-CH2-或-CH(CH3)-,则X不为0。该发明的化合物在治疗癌症和神经退行性疾病等疾病方面是有用的。